Form 8-K QUEST DIAGNOSTICS INC For: Oct 22

Go back to Form 8-K QUEST DIAGNOSTICS INC For: Oct 22

Quest Diagnostics (DGX) PT Raised to $165 at Leerink Partners

October 23, 2024 6:05 AM EDT

Leerink Partners analyst Michael Cherny raised the price target on Quest Diagnostics (NYSE: DGX) to $165.00 (from $160.00) while maintaining a Market Perform rating.

The analyst comments "Bottom Line: DGX was poised for a solid quarter given elevated utilization, even with several moving pieces hitting adjusted EBIT margins. The company delivered solid base business growth, and management continues to... More